Patents Assigned to Gencross, Inc.
  • Publication number: 20080300253
    Abstract: Methods of treating and/or preventing disorders mediated by one or more of TNF-?, NF-?B, IKK-?, IKK-?, ATF-2 and p38 kinase by administration of praziquantel, or a pharmaceutically acceptable salt, prodrug, ester or amide thereof. These disorders include inflammatory disorders such as autoimmune diseases.
    Type: Application
    Filed: May 19, 2008
    Publication date: December 4, 2008
    Applicant: Gencross, Inc.
    Inventors: Deug Yong Shin, Tae Saeng Choi, Dong Hoon Jin, Min Kyung Cho
  • Publication number: 20060173011
    Abstract: Methods of treating and/or preventing disorders mediated by one or more of TNF-?, NF-?B, IKK-?, IKK-?, ATF-2 and p38 kinase by administration of praziquantel, or a pharmaceutically acceptable salt, prodrug, ester or amide thereof. These disorders include inflammatory disorders such as autoimmune diseases.
    Type: Application
    Filed: January 17, 2006
    Publication date: August 3, 2006
    Applicant: Gencross, Inc.
    Inventors: Deug Shin, Tae Choi, Dong Jin, Min Cho